ACA 16-cAC-0001
ClinicalTrials.gov NCT03325556
Research payments
$1,884,957
Through program year 2021, $1,884,957 in research payments was reported against ACA 16-cAC-0001, across 452 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03325556
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $369,653 | 83 |
| 2020 | Research | $521,945 | 102 |
| 2019 | Research | $993,360 | 267 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Barry Vaught Beckley, WV Named on 2 payments
- Michael Kleinman Scarborough, ME Named on 2 payments
- Kara Smith Worcester, MA Named on 2 payments
- Carmen Fuentes Norfolk, VA Named on 2 payments
- Jason Aldred Spokane, WA Named on 2 payments
- Matthew Boyce Richmond, VA Named on 2 payments
- Ramon Gil Port Charlotte, FL Named on 2 payments
- Sanjay Yathiraj Bradenton, FL Named on 2 payments
- Jill Cramer Christiansburg, VA Named on 2 payments
- Ehsan Hadi Carmichael, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.